Healthcare, Regulatory and Reimbursement Landscape Russia



Summary



GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Russia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Russia’s population decreased at a CAGR of 0.1% between 2005 and 2010. As in most developed countries, the population contains a high proportion of elderly people, with approximately 13.2% of the population above the age of 65 years in 2010. The disease burden associated with this large elderly population is expected to boost growth in the pharmaceutical market, although hinder growth in the economy at the same time. Russia’s pharmaceutical market is one of the fastest growing markets in the world, and was valued at approximately $18.7 billion in 2010, having grown at a CAGR of 23% from 2005. The medical device market is one of the most stable industries in the healthcare sector. The main segments in 2010 were diagnostic imaging, ophthalmic devices, cardiovascular devices, in vitro diagnostics and diabetes care devices.

The positive trends in the healthcare market can be attributed primarily to -
- Large elderly population
- Increased government spending
- Government initiatives focusing on the prevention and management of chronic diseases
- Government efforts to simplify regulatory guidelines
- Increased prevalence of non-communicable diseases



Scope


The report provides information on the healthcare, regulatory and reimbursement landscape, and its scope includes -
- Overview of the pharmaceutical and medical devices markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analysis of the major players in the pharmaceutical and medical device markets.
- Insightful review of the reimbursement and regulatory landscape, including details of the reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices.
- A detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.



Reasons to buy


The report comprehensively covers both the pharmaceutical and the medical device markets. It will enhance your decision-making capability and allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market in Russia.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, and pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the main competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.

Table Of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11
3 Overview of the Pharmaceutical and Medical Device Market 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 16
3.1.3 Market Segments 18
3.1.4 Major Therapeutic Areas 19
3.1.5 Major Players 26
3.2 Medical Device Market 49
3.2.1 Market Overview 49
3.2.2 Overview of Top Five Segments 51
3.2.3 Major Players 61
3.3 Market Drivers and Barriers 81
3.3.1 Drivers 81
3.3.2 Barriers 82
4 Market Access 84
4.1 Reimbursement and Payer Landscape 84
4.1.1 Overview of Healthcare System 84
4.1.2 Reimbursement Process 86
4.1.3 Overview of Insurance Providers 88
4.1.4 Patient Share in Healthcare Spending 90
4.1.5 Drug Price Trends 91
4.1.6 Pricing Policies 91
4.2 Regulatory Landscape 91
4.2.1 Overview of Regulatory Agencies 91
4.2.2 New Drug Approval Process 92
4.2.3 New Device Approval Process 94
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 95
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 95
4.2.6 Intellectual Property Rights 96
4.2.7 Clinical Trial Regulations 96
4.2.8 Pharmaceutical Advertising Regulations 97
4.2.9 Labeling and Packaging Regulations 98
5 Country Analysis 99
5.1 Political Environment 99
5.1.1 Political Structure 99
5.1.2 Analysis of Current Political Environment 100
5.1.3 Healthcare Policy Initiatives 102
5.2 Economic Landscape 104
5.3 Economic Indicators 105
5.3.1 Gross Domestic Product 105
5.3.2 Gross National Income 108
5.3.3 Inflation 108
5.3.4 Currency Exchange Rate 112
5.3.5 Foreign Direct Investment 113
5.3.6 Foreign Exchange Reserves 114
5.3.7 Trade Balance 114
5.3.8 Government Structural Balance 117
5.3.9 Government Gross Debt 119
5.3.10 Major Industries 121
5.4 Demographics 122
5.4.1 Population 122
5.4.2 Education and Literacy 140
5.4.3 Employment 141
5.4.4 Disease Burden 144
5.5 Healthcare Infrastructure 146
5.5.1 Healthcare Facilities 146
5.5.2 Healthcare Parameters 153
5.5.3 Healthcare Personnel 161
5.6 Healthcare Expenditure 162
5.6.1 Overview 162
5.6.2 Major Components of Healthcare Spending 164
5.6.3 Share of Public and Private Sectors 165
5.6.4 Spending on Pharmaceutical RandD 166
5.7 Trade Associations 166
5.7.1 Association of Russian Pharmaceutical Manufacturers 166
5.7.2 Association of International Pharmaceutical Manufacturers 166
5.7.3 Russian Association of Pharmaceutical Marketing 166
5.8 Trade Fairs 167
6 Opportunities and Challenges 168
6.1 Opportunities 168
6.2 Challenges 168
7 Appendix 170
7.1 Abbreviations 170
7.2 Bibliography 172
7.3 Methodology 176
7.3.1 Coverage 176
7.3.2 Secondary Research 177
7.3.3 Forecasting 177
7.3.4 Primary Research 177
7.3.5 Expert Panel Validation 178
7.4 Contact Us 178
7.5 Disclaimer 178

List of Tables

Table 1: Pharmaceutical Market ($bn), Russia, 2005-2010 12
Table 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011-2020 13
Table 3: Sources of Pharmaceuticals, Russia, Share (%), 2008-2010 14
Table 4: Innovative and Generic Products, Russia, Market Share (%), 2007 15
Table 5: Wholesaler Mark-ups (%), Various Countries, 2008 17
Table 6: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005-2010 20
Table 7: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009 21
Table 8: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007 22
Table 9: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007 23
Table 10: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010 25
Table 11: Major Products, Novartis, Global, Revenue ($m), 2011 26
Table 12: Planned Filings, Novartis, 2012 to ? 2016 27
Table 13: Major Products, Pharmstandard, Revenue ($m), 2011 32
Table 14: Major Products, Bayer AG, Global, Revenue ($m), 2011 36
Table 15: Late-stage Pipeline, Bayer AG, 2011 36
Table 16: Major Products, Servier, 2011 42
Table 17: Major Products, Berlin-Chemie/Menarini, 2011 45
Table 18: Pipeline, Menarini, 2011 46
Table 19: Medical Device Market ($bn), Russia, 2005-2010 50
Table 20: Medical Device Market ($bn), Russia, Forecast, 2011-2020 50
Table 21: Medical Device Market, Russia, Segment Share (%), 2010 51
Table 22: Diagnostic Imaging Market ($m), Russia, 2005-2010 52
Table 23: Sales Trends for Major Players*, Diagnostic Devices, Russia, 2005-2010 53
Table 24: Ophthalmic Devices Market ($m), Russia, 2005-2010 54
Table 25: Sales Trends for Major Players*, Ophthalmic Devices, Russia, 2010 55
Table 26: Cardiovascular Devices Market ($m), Russia, 2005-2010 56
Table 27: Sales Trends for Major Players*, Cardiovascular Devices, Russia, 2010 57
Table 28: In Vitro Diagnostics Market ($m), Russia, 2005-2010 58
Table 29: Sales Trends for Major Players*, In Vitro Diagnostics, Russia, 2010 59
Table 30: Diabetes Care Devices Market ($m), Russia, 2005-2010 60
Table 31: Sales Trends for Major Players*, Diabetes Care Devices, Russia, 2010 61
Table 32: Major Medical Device Companies, Russia, Revenue ($m), 2010 61
Table 33: Major Products, Medtronic, Global, Revenue ($m), 2011 62
Table 34: Major Products, Siemens, Global, Revenue ($m), 2012 70
Table 35: Major Products, Philips Healthcare, 2012 78
Table 36: Reimbursement Drug Lists, Russia, 2011 87
Table 37: Healthcare Spending, Russia, Patient Share (%), 2005-2010 90
Table 38: Medical Equipment Classification, Russia, 2011 94
Table 39: GDP Per Capita ($), Russia, 2005-2010 105
Table 40: GDP Per Capita ($), Russia, Forecast, 2011-2020 106
Table 41: GDP, Russia, Annual Growth (%), 2005-2010 107
Table 42: GDP, Russia, Annual Growth (%), Forecast, 2011-2020 107
Table 43: GNI Per Capita ($), Russia, 2005-2010 108
Table 44: Average Consumer Price Index, Russia, 2005-2010 109
Table 45: Consumer Price, Russia, Annual Change (%), 2005-2010 110
Table 46: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011-2020 111
Table 47: Currency Exchange Rate (RUB/$), Russia, 2005-2010 112
Table 48: Foreign Direct Investment ($bn), Russia, 2005-2010 113
Table 49: Foreign Exchange Reserves ($bn), Russia, 2005-2010 114
Table 50: Imports ($bn), Russia, 2005-2010 115
Table 51: Exports ($bn), Russia, 2005-2010 116
Table 52: General Government Structural Balance ($bn), Russia, 2005-2010 117
Table 53: General Government Structural Balance ($bn), Russia, 2011-2020 118
Table 54: General Government Gross Debt ($bn), Russia, 2005-2010 119
Table 55: General Government Gross Debt ($bn), Russia, 2011-2020 120
Table 56: Major Industries, Russia, Production ($bn), 2010 121
Table 57: Population (m), Russia, 2005-2010 123
Table 58: Population (m), Russia, Forecast, 2011-2020 124
Table 59: Urban and Rural Population, Russia, Share (%), 2005-2010 125
Table 60: Urban and Rural Population, Russia, Share (%), Forecast, 2011-2020 126
Table 61: Age Groups, Russia, Population Distribution (%), 2005-2010 127
Table 62: Age Groups, Russia, Population Distribution (%), Forecast, 2011-2020 128
Table 63: Births (Per 1,000 Population), Russia, 2005-2010 129
Table 64: Births (Per 1,000 Population), Russia, Forecast, 2011-2020 130
Table 65: Mortality (Per 1,000 Population), Russia, 2005-2010 131
Table 66: Mortality (Per 1,000 Population), Russia, Forecast, 2011-2020 132
Table 67: Major Causes of Mortality (‘000s), Russia, 2008 133
Table 68: Children Table 69: Immunization Rate (%), Russia, 2005-2010 135
Table 70: Major Causes of Male Mortality (‘000s), Russia, 2008 136
Table 71: Major Causes of Female Mortality (‘000s), Russia, 2008 137
Table 72: Gender Ratio (M/F), Russia, 2005-2010 138
Table 73: Life Expectancy at Birth (Years), Russia, 2005-2010 139
Table 74: Life Expectancy at Birth (Years), Russia, Forecast, 2011-2020 140
Table 75: Students (‘000s), Russia, 2005-2010 141
Table 76: Unemployment Rate (%), Russia, 2005-2010 142
Table 77: Employees, Russia, Segment Share (%), 2008 143
Table 78: Major Diseases, Russia, Incidence (‘000s), 2008 144
Table 79: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004 145
Table 80: Hospitals, Russia, 2005-2010 146
Table 81: Out-patient Clinics, Russia, 2005-2010 147
Table 82: Out-patient Clinics, Russia, Urban-Rural, 2005-2010 148
Table 83: Dental Clinics, Russia, 2005-2010 149
Table 84: Public Hospitals, Russia, 2005-2010 150
Table 85: Private Hospitals, Russia, 2005-2010 151
Table 86: Hospital Beds by Specialization (‘000s), Russia, 2010 152
Table 87: Beds (Per 1,000 Population), Russia, 2005-2010 153
Table 88: Physicians (Per 1,000 Population), Russia, 2005-2010 154
Table 89: Physicians by Specialization (‘000s), Russia, 2010 155
Table 90: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004 156
Table 91: Common Air Pollutants (Million Tons), Russia, 2005-2010 157
Table 92: PM10 (micrograms per cubic meter), Russia, 2005-2010 158
Table 93: CO2 Emissions (Million Tons), Russia, 2005-2010 159
Table 94: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005-2010 160
Table 95: Healthcare Personnel, Russia, Share (%), 2010 161
Table 96: Healthcare Expenditure (% of GDP), Russia, 2005-2010 162
Table 97: Healthcare Expenditure (% of GDP), Russia, 2011-2020 163
Table 98: Healthcare Expenditure, Russia, Share of Major Components (%), 2007 164
Table 99: Healthcare Expenditure, Russia, Public-Private Share (%), 2005-2010 165
Table 100: Major Healthcare Trade Fairs, Russia 167

List of Figures

Figure 1: Pharmaceutical Market ($bn), Russia, 2005-2010 12
Figure 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011-2020 13
Figure 3: Sources of Pharmaceuticals, Russia, Share (%), 2008-2010 14
Figure 4: Innovative and Generic Products, Russia, Market Share (%), 2007 15
Figure 5: Distribution Channels, Russia, 2011 16
Figure 6: Wholesaler Mark-ups (%), Various Countries, 2008 17
Figure 7: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005-2010 20
Figure 8: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009 21
Figure 9: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007 22
Figure 10: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007 23
Figure 11: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010 25
Figure 12: Medical Device Market ($bn), Russia, 2005-2010 49
Figure 13: Medical Device Market ($bn), Russia, Forecast, 2011-2020 50
Figure 14: Medical Device Market, Russia, Segment Share (%), 2010 51
Figure 15: Diagnostic Imaging Market ($m), Russia, 2005-2010 52
Figure 16: Sales Trends for Major Players*, Diagnostic Devices, Russia, 2005-2010 53
Figure 17: Ophthalmic Devices Market ($m), Russia, 2005-2010 54
Figure 18: Sales Trends for Major Players*, Ophthalmic Devices, Russia, 2005-2010 55
Figure 19: Cardiovascular Devices Market ($m), Russia, 2005-2010 56
Figure 20: Sales Trends for Major Players*, Cardiovascular Devices, Russia, 2005-2010 57
Figure 21: In Vitro Diagnostics Market ($m), Russia, 2005-2010 58
Figure 22: Sales Trends for Major Players*, In Vitro Diagnostics, Russia, 2005-2010 59
Figure 23: Diabetes Care Devices Market ($m), Russia, 2005-2010 60
Figure 24: Sales Trends for Major Players*, Diabetes Care Devices, Russia, 2005-2010 60
Figure 25: Major Medical Device Companies, Russia, Revenue ($m), 2010 61
Figure 26: Drivers and Barriers, Healthcare Market, Russia, 2012 83
Figure 27: Organizational Structure of the Healthcare System, Russia, 2011 85
Figure 28: Health Service Financing, Russia, 2011 86
Figure 29: Inclusion Process for Reimbursement List, Russia, 2011 88
Figure 30: Healthcare Spending, Russia, Patient Share (%), 2005-2010 90
Figure 31: New Drug Approval Process, Russia, 2011 93
Figure 32: Political System, Russia, 2012 100
Figure 33: Pharma-2020 Strategy, Russia, 2009 103
Figure 34: GDP Per Capita ($), Russia, 2005-2010 105
Figure 35: GDP Per Capita ($), Russia, Forecast, 2011-2020 106
Figure 36: GDP, Russia, Annual Growth (%), 2005-2010 106
Figure 37: GDP, Russia, Annual Growth (%), Forecast, 2011-2020 107
Figure 38: GNI Per Capita ($), Russia, 2005-2010 108
Figure 39: Average Consumer Price Index, Russia, 2005-2010 109
Figure 40: Consumer Price, Russia, Annual Change (%), 2005-2010 110
Figure 41: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011-2020 111
Figure 42: Currency Exchange Rate (RUB/$), Russia, 2005-2010 112
Figure 43: Foreign Direct Investment ($bn), Russia, 2005-2010 113
Figure 44: Foreign Exchange Reserves ($bn), Russia, 2005-2010 114
Figure 45: Imports ($bn), Russia, 2005-2010 115
Figure 46: Exports ($bn), Russia, 2005-2010 116
Figure 47: General Government Structural Balance ($bn), Russia, 2005-2010 117
Figure 48: General Government Structural Balance ($bn), Russia, 2011-2020 118
Figure 49: General Government Gross Debt ($bn), Russia, 2005-2010 119
Figure 50: General Government Gross Debt ($bn), Russia, 2011-2020 120
Figure 51: Major Industries, Russia, Production ($bn), 2010 121
Figure 52: Population (m), Russia, 2005-2010 123
Figure 53: Population (m), Russia, Forecast, 2011-2020 124
Figure 54: Urban and Rural Population, Russia, Share (%), 2005-2010 125
Figure 55: Urban and Rural Population, Russia, Share (%), Forecast, 2011-2020 126
Figure 56: Age Groups, Russia, Population Distribution (%), 2005-2010 127
Figure 57: Age Groups, Russia, Population Distribution (%), Forecast, 2011-2020 128
Figure 58: Births (Per 1,000 Population), Russia, 2005-2010 129
Figure 59: Births (Per 1,000 Population), Russia, Forecast, 2011-2020 130
Figure 60: Mortality (Per 1,000 Population), Russia, 2005-2010 131
Figure 61: Mortality (Per 1,000 Population), Russia, Forecast, 2011-2020 132
Figure 62: Major Causes of Mortality (‘000s), Russia, 2008 133
Figure 63: Children Figure 64: Immunization Rate (%), Russia, 2005-2010 135
Figure 65: Major Causes of Male Mortality (‘000s), Russia, 2008 136
Figure 66: Major Causes of Female Mortality (‘000s), Russia, 2008 137
Figure 67: Gender Ratio (M/F), Russia, 2005-2010 138
Figure 68: Life Expectancy at Birth (Years), Russia, 2005-2010 139
Figure 69: Life Expectancy at Birth (Years), Russia, Forecast, 2011-2020 140
Figure 70: Students (‘000s), Russia, 2005-2010 141
Figure 71: Unemployment Rate (%), Russia, 2005-2010 142
Figure 72: Employees, Russia, Segment Share (%), 2008 143
Figure 73: Major Diseases, Russia, Incidence (‘000s), 2008 144
Figure 74: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004 145
Figure 75: Hospitals, Russia, 2005-2010 146
Figure 76: Out-patient Clinics, Russia, 2005-2010 147
Figure 77: Out-patient Clinics, Russia, Urban-Rural, 2005-2010 148
Figure 78: Dental Clinics, Russia, 2005-2010 149
Figure 79: Public Hospitals, Russia, 2005-2010 150
Figure 80: Private Hospitals, Russia, 2005-2010 151
Figure 81: Hospital Beds by Specialization (‘000s), Russia, 2010 152
Figure 82: Beds (Per 1,000 Population), Russia, 2005-2010 153
Figure 83: Physicians (Per 1,000 Population), Russia, 2005-2010 154
Figure 84: Physicians by Specialization (‘000s), Russia, 2010 155
Figure 85: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004 156
Figure 86: Common Air Pollutants (Million Tons), Russia, 2005-2010 157
Figure 87: PM10 (Microgram Per Cubic Meter), Russia, 2005-2010 158
Figure 88: CO2 Emissions (Million Tons), Russia, 2005-2010 159
Figure 89: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005-2010 160
Figure 90: Healthcare Personnel, Russia, Share (%), 2010 161
Figure 91: Healthcare Expenditure (% of GDP), Russia, 2005-2010 162
Figure 92: Healthcare Expenditure (% of GDP), Russia, 2011-2020 163
Figure 93: Healthcare Expenditure, Russia, Share of Major Components (%), 2007 164
Figure 94: Healthcare Expenditure, Russia, Public-Private Share (%), 2005-2010 165
Figure 95: Opportunities and Challenges, Healthcare Market, Russia, 2012 169

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.